Mimedx Group Inc (MDXG) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mimedx Group Inc   (NASDAQ: MDXG)


Mimedx Group Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mimedx Group Inc's ROI in the second quarter of 2026?
Mimedx Group Inc achieved a return on average invested assets (ROI) of 2.38 % in its second quarter of 2026, this is above MDXG's average return on investment of -5.94%.
Mimedx Group Inc invested over the 12 months ending in its second quarter of 2026 $262 million

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 41 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 272 to 667.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 17.4 % 24.28 % 27.28 % 24.32 % 25.87 %
Y / Y Net Income Change TTM -80.61 % -23.61 % 46.5 % 58.74 % 82.55 %
Investment (TTM) in Millions 243 264 278 261 241
Return On Investment (TTM) 2.38 % 11.75 % 19.27 % 17.18 % 14.44 %
MDXG's Overall Ranking # 667 # 272 # 199 # 362 # 367
Seq. Investment Change TTM 0.16 % 3.6 % 6.07 % 6.66 % 6.03 %
Seq. Net Income Change TTM -79.68 % -36.81 % 18.98 % 26.89 % -19.93 %
Net Income (TTM) in Millions 6 31 49 41 32

MDXG Company Profile >> Back to MDXG Roi Comparisons >> See Annual MDXG Return On Investment



Return On Investment MDXG's Ranking
Within: No.
Industry # 12
Sector # 42
Overall # 667

Return On Investment Statistics
High Average Low
52.15 %
-5.94 %
-106.58 %
(Jun 30 2024)   (Sep 30 2019)







Financial Statements
Mimedx Group Inc's II. Quarter Investments $ 243 Millions MDXG's Balance sheet
Mimedx Group Inc's II. Quarter Income $ -15 Millions Quarterly MDXG's Income Statement
MDXG's Income by Division See MDXG's Income by Division


MDXG Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 278 218 193 128 146
Y / Y Investment Growth 27.51 % 13.1 % 50.96 % -12.16 % 1.89 %
Net Income in Millions 49 42 58 -37 -16
Y / Y Net Income Growth 14.52 % -27.15 % - - -
Annual Return On Investment 17.45 % 19.43 % 30.16 % -28.76 % -11.28 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 17.45 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MDXG's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MDXG's Competitors
Subscribers only: Roi for Mimedx Group Inc's Suppliers
Subscribers only: Return On Investment for MDXG's Customers

Other Ratios
MDXG's Roa MDXG's Inventory Turnover Ratio MDXG's Growth Rates MDXG's Dividend Statistics
MDXG's Profitability Ratios MDXG's Asset Turnover Ratio MDXG's Dividend Growth
MDXG's Roe MDXG's Valuation Ratios MDXG's Financial Strength Ratios MDXG's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Medtronic Plc  6.46 %
Siga Technologies Inc  6.45 %
Labcorp Holdings Inc   6.11 %
Royalty Pharma Plc  6.09 %
Pacs Group Inc   5.86 %
Merit Medical Systems Inc  5.80 %
Ensign Group Inc  5.75 %
Nrc Health  5.72 %
IMPACT BIOMEDICAL INC.  5.68 %
Vericel Corporation  5.58 %
Amphastar Pharmaceuticals Inc   5.33 %
Sotera Health Company  5.21 %
The Cooper Companies Inc   5.09 %
Henry Schein Inc   5.06 %
Cadre Holdings inc   4.92 %
Haemonetics Corporation  4.91 %
The Pennant Group Inc   4.62 %
Vaso Corporation  4.40 %
Zimmer Biomet Holdings Inc   3.97 %
U S Physical Therapy Inc  3.91 %
Privia Health Group Inc   3.90 %
Integer Holdings Corporation  3.88 %
Ardent Health Inc   3.74 %
Collegium Pharmaceutical Inc   3.72 %
Merck and Co Inc   3.24 %
Community Health Systems Inc   3.12 %
National Vision Holdings Inc   2.99 %
Teva Pharmaceutical Industries Limited  2.66 %
Lifestance Health Group Inc   2.61 %
Conmed Corporation  2.57 %

Date modified: 2026-09-08T20:53:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.